Healthcare Costs

Five things for pharma marketers to know: Friday, March 17, 2017

Five things for pharma marketers to know: Friday, March 17, 2017

By

The FDA delays final rule related to off-label use; Amgen's Repatha reduces risk of death by 20%, study finds; FDA rejects AstraZeneca's hyperkalaemia drug

The Transforming Healthcare Virtual Event Series: Patient-Focused Design

The Transforming Healthcare Virtual Event Series: Patient-Focused Design

This event will focus on the wide-ranging application of this thinking in healthcare, identify the latest trends in achieving patient engagement, and share standout examples and new insights.

Reframing the Debate: Why Drug Spending Can Lower Costs

Reframing the Debate: Why Drug Spending Can Lower Costs

Rising healthcare costs, coupled with high-profile stories of price gouging at some small pharmaceutical companies, have left consumers feeling ripped off